GREENFIELD, Ind., March 17, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced changes to its Board of Directors that will reduce the Board size to 11 directors by the 2025 Annual Meeting of Shareholders: John P. (JP) Bilbrey, Kathy Turner and Craig...
Hence then, the article about elanco announces changes to board of directors signs research agreement to explore novel therapies for chronic kidney disease and life extension in pets was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets )
Also on site :
- KLOS-FM host Uncle Joe Benson, one LA radio’s legendary voices, dies at 76
- Fitness Influencer Lee ‘Malibu’ Markham Admits He Falsely Claimed IED Injury
- OpenAI says Canada mass shooter evaded ban with second ChatGPT account